Vardenafil Tablet
Product Images NDC 33342-203

10 FDA label images from Macleods Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Vardenafil (NDC 33342-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vardi-carton (Vardenafil Carton 4s)

Vardi-carton (Vardenafil Carton 4s)
Packaging label for Vardenafil Hydrochloride Orally Disintegrating Tablets 10 mg, manufactured by Macleods Pharmaceuticals Ltd. The label includes dosing instructions, a notice for pharmacists, and a barcode. The label indicates the product is in unit-dose blister packaging containing 4 tablets and includes storage information. The labeler listed is Macleods Pharma USA, Inc.*
FDA Label Image

Vardenafil-fig-1 (Vardenafil Fig 1)

Vardenafil-fig-1 (Vardenafil Fig 1)
A set of three line graphs depicting the mean maximal changes in systolic blood pressure (mmHg), diastolic blood pressure (mmHg), and heart rate (bpm) over time during Vardenafil treatment before NTG administration. The x-axis represents timing of Vardenafil treatment, and y-axes show respective physiological measurements with error bars indicating variability.*
FDA Label Image

Vardenafil-fig-2 (Vardenafil Fig 2)

Vardenafil-fig-2 (Vardenafil Fig 2)
A line graph displaying mean change in mmHg over time (hours) comparing placebo and Vardenafil 5 mg under simultaneous and 6-hour separation conditions. The x-axis represents time in hours, and the y-axis shows mean change in mmHg, with multiple lines illustrating the different conditions and treatment groups.*
FDA Label Image

Vardenafil-fig-3 (Vardenafil Fig 3)

Vardenafil-fig-3 (Vardenafil Fig 3)
A line graph showing mean change in mmHg over time (hours) for placebo and vardenafil 5 mg under simultaneous and 8-hour separation conditions. The graph plots four lines depicting blood pressure changes over 6 hours for each treatment group.*
FDA Label Image

Vardenafil-fig-4 (Vardenafil Fig 4)

Vardenafil-fig-4 (Vardenafil Fig 4)
A line graph showing mean change in mmHg over time (hours) for four groups: Placebo Stage 1, Placebo Stage 2, Vardenafil 10 mg, and Vardenafil 20 mg. The x-axis represents time in hours up to 6 hours, and the y-axis shows mean change in mmHg, with values ranging approximately from -10 to 5.*
FDA Label Image

Vardenafil-fig-5 (Vardenafil Fig 5)

Vardenafil-fig-5 (Vardenafil Fig 5)
A line graph depicting mean change in mmHg over time (0 to 6 hours) for Vardenafil at 5 mg and 10 mg doses compared with placebo across two stages. The graph shows trends in blood pressure changes for each group with different markers for each dose and placebo stage.*
FDA Label Image

Vardenafil-fig-6 (Vardenafil Fig 6)

Vardenafil-fig-6 (Vardenafil Fig 6)
A line graph titled 'TERAZOSIN' depicting mean change in mmHg over time (hours) from 0 to 6 hours. The graph compares placebo and two doses of Vardenafil (10 mg and 20 mg) under separate and simultaneous administration conditions, showing trends in blood pressure changes over the 6-hour period.*
FDA Label Image

Vardenafil-fig-7 (Vardenafil Fig 7)

Vardenafil-fig-7 (Vardenafil Fig 7)
A line graph illustrating the mean change in mmHg over time (hours) following different treatments involving Tamsulosin and Vardenafil. It compares placebo versus Vardenafil at 20 mg under two conditions: separation and simultaneous administration over a 6-hour period.*
FDA Label Image

Vardenafil-fig-8 (Vardenafil Fig 8)

Vardenafil-fig-8 (Vardenafil Fig 8)
A line graph displaying plasma concentration (µg/L) over time (hours) up to 16 hours. It illustrates the pharmacokinetic profile of a substance, showing plasma concentration rising sharply, peaking before gradually declining over time, with error bars indicating variability at different points.*
FDA Label Image

Vardenafil-str (Vardenafil Str)

Vardenafil-str (Vardenafil Str)
Chemical structure diagram of Vardenafil, depicting its molecular framework with labeled chemical groups and bonds. The image includes notation for the hydrochloride and hydrate forms indicating N HCl x 3H2O.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.